CKD Report Card Pilot Trial

CKD Clinical Trial

Official title:

Pilot and Trial of the Chronic Kidney Disease Report Card

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04119570
• Other study ID #: 18-0283
• Status: Completed
• Phase: N/A
• Start date: May 15, 2018
• Est. completion date: September 15, 2018

Study information

• Verified date: May 2023
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators will study physician-patient communication at the UCMC nephrology fellow clinic and to test an intervention, the CKD Report Card, to improve that communication and patient knowledge of CKD.

Description:

The goals of the study are to 1) characterize the effectiveness and patient-centeredness of patient-physician interaction during a nephrology clinic visit both with and without use of the CKD Report Card, and 2) to determine which physician and patient characteristics are associated with effective and patient centered communication. There will be block enrollment. For Nephrology physicians who agreed to participate will complete a baseline questionnaire. Research assistants will approach patients of participating providers in clinic waiting rooms, with the goal of enrolling patients for each provider For half of the study, investigators will enroll patients in the study and observe patient-physician communication and use a survey measure CKD knowledge pre-visit and post-visit. For the second half of the study, investigators will give participants the CKD Report Card, an investigator-developed handout, to use during the clinic visit. Investigators will observe patient-physician communication and use a survey to measure CKD knowledge pre-visit and post-visit. For both groups, eligible participants will give informed consent and will complete a baseline questionnaire; research assistants will place a digital audio-recording device in the examination room to record the patient-provider encounter. Following the medical encounter, research assistants will administered an interview with patients, assessing demographic, social, and behavioral characteristics, as well as their experience of care and ratings of provider communication.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 15, 2018
• Est. primary completion date: September 15, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• English-speaking adult patients (age 18 or older)

• Identified in the medical record as non-Hispanic Black or non- Hispanic White

• seen in University of Chicago nephrology clinic with a participating nephrologist

Exclusion Criteria:

• not able to communicate in English

• lacking ability to consent to study

• does not identify as non-Hispanic Black or non-Hispanic

• without chronic kidney disease

Related Conditions & MeSH terms

• CKD

Intervention

Behavioral:
• CKD Report Card
The CKD Report Card is a handout based on a NKDEP Educational Sheet that includes basic information about kidney disease and spaces where patient can record information about their own kidney disease

Locations

Country	Name	City	State
United States	University of Chicago Medical Center	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CKD Knowledge	Kidney Disease Knowledge Survey (KiKs)	Change in CKD Knowledge from Baseline (pre-visit) to CKD Knowledge immediately post clinic visit (within 15-100 minutes post-clinic visit)
Secondary	patient-physician interaction	Perceived efficacy in patient-physician interactions (PEPPI)	immediately post-nephrology clinic visit (on day of enrollment, within 15-100 minutes post-clinic visit)
Secondary	communication assessment	communication assessment tool (CAT)	immediately post-nephrology clinic visit (on day of enrollment, within 15-100 minutes post-clinic visit)